Diwan, A. D. & Melrose, J. Intervertebral disc degeneration and how it leads to low back pain. JOR Spine 6, e1231 (2023).
Article CAS PubMed Google Scholar
Gill, T. K. et al. Global, regional, and national burden of other musculoskeletal disorders, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 5, e670–e682 (2023).
Mengis, T. et al. Intervertebral disc microbiome in Modic changes: lack of result replication underscores the need for a consensus in low-biomass microbiome analysis. JOR Spine 7, e1330 (2024).
Article CAS PubMed PubMed Central Google Scholar
Burt, K. G., Kim, M. K. M., Viola, D. C., Abraham, A. C. & Chahine, N. O. Nuclear factor κB overactivation in the intervertebral disc leads to macrophage recruitment and severe disc degeneration. Sci. Adv. 10, eadj3194 (2024).
Article CAS PubMed PubMed Central Google Scholar
Chen, F. et al. Serglycin secreted by late-stage nucleus pulposus cells is a biomarker of intervertebral disc degeneration. Nat. Commun. 15, 47, 9 (2024).
Article CAS PubMed Google Scholar
Capoor, M. N. et al. Prevalence of Propionibacterium acnes in intervertebral discs of patients undergoing lumbar microdiscectomy: a prospective cross-sectional study. PLoS ONE 11, e0161676 (2016).
Article PubMed PubMed Central Google Scholar
Rajasekaran, S. et al. “Are we barking up the wrong tree? Too much emphasis on Cutibacterium acnes and ignoring other pathogens”— a study based on next-generation sequencing of normal and diseased discs. Spine J. 23, 1414–1426 (2023).
Song, C. et al. An in-depth analysis of the immunomodulatory mechanisms of intervertebral disc degeneration. JOR Spine 5, e1233 (2022).
留言 (0)